Abstract
Background
Ventricular assist devices (VADs) have provided a temporising solution to many individuals with refractory heart failure (HF) while awaiting a suitable donor for heart transplantation which remains the gold standard in treatment. Many of the discussions around VADs involve ongoing morbidity; however, one aspect of VADs that is often overlooked is the utility of their log files. We decided to review the literature for mentions of the clinical utility of VAD log files.
Methods
A keyword search was utilised on PUBMED using the terms ‘Ventricular Assist Device’ and ‘Log files’. Perhaps unsurprisingly, this search only yielded 4 results with further articles being discovered through the bibliography of these publications.
Results
The 4 identified articles provided basic information on log files, particularly with reference to the HVAD. Logs can be categorised into three types—data (pump parameters), events (changes in parameters) and alarms (abnormal function). Using a combination of these logs, we can readily identify abnormal pump operation such as the development and progression of pump thrombosis, suction events and gastrointestinal bleeding. However, the research potential of log files was not discussed in these publications, particularly as it pertains to areas such as studying speed modulation and pulsatility in VADs.
Conclusions
VADs are an important staple in the treatment of patients with refractory HF. Log files provide a treasure-trove of information and knowledge that can be utilised for clinical benefit. Furthermore, log files provide an excellent tool for conducting research into device functionality. Current literature on the clinical utility of log files is sparse with much untapped potential.
Similar content being viewed by others
References
Norton C, Georgiopoulou VV, Kalogeropoulos AP, Butler J. Epidemiology and Cost of Advanced Heart Failure. Prog Cardiovasc Dis. 2011;54:78–85.
Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139:e56–e528.
Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Eng J Med. 2001;345:1435–43.
Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137–61.
Kadakia S, Moore R, Ambur V, Toyoda Y. Current status of the implantable LVAD. Gen Thorac Cardiovasc Surg. 2016;64:501–8.
Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report—2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:996–1008.
Mehra MR. Guidelines for Listing Candidates for Heart Transplant: A 10-Year Update. JAMA Cardiol. 2017;2:98–9.
Lim HS, Howell N, Ranasinghe A. The physiology of continuous-flow left ventricular assist devices. J Card Fail. 2017;23:169–80.
Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Eng J Med. 2009;361:2241–51.
Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.
Rigatelli G, Santini F, Faggian G. Past and present of cardiocirculatory assist devices: a comprehensive critical review. J Geriatr Cardiol. 2012;9:389–400.
Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Eng J Med. 2017;376:451–60.
Kirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017;36:1080–6.
Silva EJ. Mechanical circulatory support: current status and future directions. Prog Cardiovasc Dis. 2016;58:444–54.
Consolo F, Esposti F, Gustar A, De Bonis M, Pappalardo F. Log files analysis and evaluation of circadian patterns for the early diagnosis of pump thrombosis with a centrifugal continuous-flow left ventricular assist device. J Heart Lung Transplant. 2019;38:1077–86.
Jorde UP, Aaronson KD, Najjar SS, et al. Identification and management of pump thrombus in the heartware left ventricular assist device system: a novel approach using log file analysis. JACC: Heart Fail. 2015;3:849–56.
Rame JE, Birati EY. HeartWare left ventricular assist device pump thrombosis: a shift away from ramp. JACC Heart Fail. 2015;3:857–9.
Chorpenning K, Brown MC, Voskoboynikov N, Reyes C, Dierlam AE, Tamez D. HeartWare controller logs a diagnostic tool and clinical management aid for the HVAD pump. ASAIO J. 2014;60:115–8.
Slaughter MS, Ising MS, Tamez D, et al. Increase in circadian variation after continuous-flow ventricular assist device implantation. J Heart Lung Transplant. 2010;29:695–7.
Suzuki K, Nishinaka T, Miyamoto T, Ichihara Y, Yamazaki K. Circadian variation of motor current observed in fixed rotation speed continuous-flow left ventricular assist device support. J Artif Organs. 2014;17:157–61.
Hu SX, Keogh AM, Macdonald PS, et al. Interaction between physical activity and continuous-flow left ventricular assist device function in outpatients. J Card Fail. 2013;19:169–75.
Muthiah K, Gupta S, Otton J, et al. Body position and activity, but not heart rate, affect pump flows in patients with continuous-flow left ventricular assist devices. JACC Heart Fail. 2014;2:323–30.
Akin S, Soliman OI, Constantinescu AA, et al. Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II. Neth Heart J. 2016;24:134–42.
Dang G, Epperla N, Muppidi V, et al. Medical management of pump-related thrombosis in patients with continuous-flow left ventricular assist devices:a systematic review and meta-analysis. ASAIO J. 2017;63:373–85.
Tchantchaleishvili V, Sagebin F, Ross RE, Hallinan W, Schwarz KQ, Massey HT. Evaluation and treatment of pump thrombosis and hemolysis. Ann Cardiothorac Surg. 2014;3:490–5.
Mehra MR, Salerno C, Naka Y, et al. A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2018;37:1281–4.
Duero Posada JG, Moayedi Y, Alhussein M, et al. Outflow graft occlusion of the HeartMate 3 left ventricular assist device. Circ Heart Fail. 2017;10:pii.e004275.
Salerno CT, Sundareswaran KS, Schleeter TP, Moanie SL, Farrar DJ, Walsh MN. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014;33:809–15.
Tibrewala A, Nassif M, Raymer D, et al. Early elevated pump power and associated hemolysis amongst HeartMate II left ventricular assist devices. J Cardiac Fail. 2015;21:S39–40.
Rich JD, Burkhoff D. HVAD flow waveform morphologies: theoretical foundation and implications for clinical practice. ASAIO J. 2017;63:526–35.
Zimpfer D, Strueber M, Aigner P, et al. Evaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice. Eur J Cardiothorac Surg. 2016;50:839–48.
Investigators, A.S. Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform. 2019; Available from: https://clinicaltrials.gov/ct2/show/NCT03697980.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
CSH is a consultant for Medtronic and Abbott and has received research funds from Medtronic. Informed consent, an ethical statement and human/animal rights considerations were not applicable given this was a review article.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Emmanuel, S., Engelman, J. & Hayward, C.S. Reviewing the clinical utility of ventricular assist device log files. Indian J Thorac Cardiovasc Surg 36 (Suppl 2), 247–255 (2020). https://doi.org/10.1007/s12055-019-00891-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-019-00891-2